Ecuador

Distribuidora Farmaceutica Ecuatoriana S.A. (DIFARE)

An EMIS Company Report EMIS is a Euromoney Institutional Investor plc company USD 29.95 Industry: Drugs and Druggists' Sundries Merchant Wholesalers Available in: English & Spanish Format: PDF Download Most recent financial data: 2016 Buy full report

What’s included?

This report extracts all available information about this company from EMIS' database of company information. The Table of Contents on the right indicates the categories of information that will be included in your report upon purchase.

Download a sample report

Company Tear Sheet (locked content will be provided in the purchased report)

Contact Information

Headquarters
Av. Rodrigo Chavez Solar 5, Icio Corporativo I Bldg.
Guayaquil; Guayas; Map

Tel: +593-4-373-, +593-98688

Email:
@grupodifare.com, glenda.lainez@grupodifare.com

Website:
http://www.grupodifare.com

Company Description
Distribuidora Farmaceutica Ecuatoriana S.A. (DIFARE) is a group of Ecuadorian companies that are dedicated to the development of the pharmaceutical market in the country, specialising in the distribution and the supply of products for the local pharmacies. The company was established in 1987 in Guayaquil, Republic of Ecuador and it is a subsidiary of Holding Grupo Difare Cía. Ltda., also headquartered in Ecuador. In 1995 the company expands its operations and opens offices in Quito and Cuenca. The DIFARE Group has three business divisions: Distribution, Pharmacy Development and Product Representations. The Group is comprised of its own pharmacies and franchises under the trade names ¨Pharmacy´s¨, ¨Farmacias Comunitarias¨ and ¨Cruz Azul¨. Through strong partnerships with pharmaceutical laboratories, the Product Representations Division develops national and international brands, among which are Menticol, Mentol Chino, Lacteol, Cipran, among others. The business units through which it produces are: Pharma, OTC Consumption and Stein. The company has a technology company Desarrollo Integral de Soluciones Empresariales DIRES S.A., which aims to develop innovative solutions for the improvement of the corporate business. Likewise, DIFARE has integrated the ¨Neptuno¨ system in order to administer pharmacies. FEDIFARE, an Educational Foundation, was founded in 2004 with the purpose of offering academic programs for people working in the pharmaceutical sector.
NAICS Industry Classification
Basic Information
Key Executives
Ownership Details
Key Financial Highlights
Financial Performance Charts
Top Competitors

Financial Statements

Annual Statements

EMIS Credit Analytics

EMIS Benchmark Score

What this report allows you to do

EMIS company reports provide the data you need to make accurate assessments about businesses you are interested in.

Identify sales opportunities

  • Does the company match your target demographic?
  • Who are the key executives?

Conduct risk assessment

  • Is the company creditworthy?
  • Is it financially stable?

Carry out strategic research

  • Is the company a potential business partner/investment opportunity?
  • What is its financial performance?

You’re in good company

EMIS company reports are used extensively by the world’s biggest companies, financial institutions, professional service companies and universities to assess businesses in emerging markets.

800,000+

company profiles

We have information on both public and private companies across 125 countries.

2,000+

clients

EMIS is the go-to information source on emerging market companies for the world’s most prestigious businesses.

Enterprise ACCESS

If you need regular and ongoing access to company information, you should consider a subscription to the full EMIS service.

EMIS company profiles are part of a larger information service where that combines company, industry and country data and analysis for over 125 emerging markets on a unique information platform.

REQUEST A DEMO
Contact us to learn more about our business solutions.
FOLLOW US
Sign up to our newsletter

Make sure you’re not the last to know by getting the latest insights on emerging markets straight to your inbox.